Jie et al. also found that intra-tumoral FOXP3+ Tregs in HNSCC patients produce an immunosuppressive TME through the upregulation of immune checkpoint receptors [38]. This evidence concerns the gene FOXP3 and head and neck squamous cell carcinoma.